Levobetaxolol Hydrochloride

盐酸左倍他洛尔

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLevobetaxolol Hydrochloride
Drug Alias NamelevobetaxolollevobetaxololumBetaxonAL-1577AL-1577A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonists
TargetsBeta-1 adrenergic receptor
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleOcular Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2000/02/23
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co Ltd
Inactive CompaniesAlcon Pharmaceuticals Ltd
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeS01
Related LinksWikipediaDrugBankKEGG